These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11385444)

  • 1. Israel's great expectations.
    Watzman H; Avitzour SP
    Nat Biotechnol; 2001 Jun; 19(6):518-20. PubMed ID: 11385444
    [No Abstract]   [Full Text] [Related]  

  • 2. Policy differences 'threaten Israel's biotech potential'.
    Watzman H
    Nature; 1996 Dec; 384(6608):396. PubMed ID: 8945450
    [No Abstract]   [Full Text] [Related]  

  • 3. Israel's population: the challenge of pluralism.
    Friedlander D; Goldscheider C
    Popul Bull; 1984 Apr; 39(2):3-39. PubMed ID: 12312873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Save the fledgling research in Israel's Hospital.
    Gilad GM; Beller U
    Isr Med Assoc J; 2000 Dec; 2(12):957. PubMed ID: 11344788
    [No Abstract]   [Full Text] [Related]  

  • 5. Singapore--biotechnology development.
    Patel SH
    Clin Invest Med; 2005 Feb; 28(1):12-4. PubMed ID: 15770877
    [No Abstract]   [Full Text] [Related]  

  • 6. Ireland embraces biotechnology.
    Canning S
    Nat Biotechnol; 2000 Mar; 18(3):273-5. PubMed ID: 10700138
    [No Abstract]   [Full Text] [Related]  

  • 7. Portugal opens its borders to biotechnology.
    Louët S
    Nat Biotechnol; 2000 Mar; 18(3):276-7. PubMed ID: 10700139
    [No Abstract]   [Full Text] [Related]  

  • 8. Ontario--hot biotechnology in a cold climate.
    McIntyre H
    Nat Biotechnol; 2001 Jun; 19(6):523-5. PubMed ID: 11385446
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology in the Bay.
    Niiler E
    Nat Biotechnol; 2000 Mar; 18(3):280-1. PubMed ID: 10700141
    [No Abstract]   [Full Text] [Related]  

  • 10. Putting a price on biotechnology.
    Stewart JJ; Allison PN; Johnson RS
    Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634
    [No Abstract]   [Full Text] [Related]  

  • 11. Vision in venture: Israel's high-tech incubator program. Interview by Catarina Wylie.
    Smoler Y; Rhodes S; Kfir T
    Cell Cycle; 2011 Mar; 10(6):855-8. PubMed ID: 21389769
    [No Abstract]   [Full Text] [Related]  

  • 12. Vapornomics.
    Paris M
    Nat Biotechnol; 2001 Apr; 19(4):301. PubMed ID: 11283574
    [No Abstract]   [Full Text] [Related]  

  • 13. Dreams and reality.
    Nat Biotechnol; 2001 Dec; 19(12):1087. PubMed ID: 11731760
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid growth in Israel's life science industry.
    Barki T
    Drug Discov Today; 2005 Dec; 10(23-24):1591-3. PubMed ID: 16376817
    [No Abstract]   [Full Text] [Related]  

  • 15. Boosting biotech in Finland.
    Smaglik P
    Nature; 2004 Oct; 431(7011):1020-1. PubMed ID: 15496931
    [No Abstract]   [Full Text] [Related]  

  • 16. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nat Biotechnol; 2002 May; 20(5):437-40. PubMed ID: 11981550
    [No Abstract]   [Full Text] [Related]  

  • 17. Fickle financing climate continues.
    Mitchell P
    Nat Biotechnol; 2001 Aug; 19(8):695-6. PubMed ID: 11479542
    [No Abstract]   [Full Text] [Related]  

  • 18. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 19. When will Israeli biotech grow up?
    Katsnelson A
    Nat Biotechnol; 2005 Nov; 23(11):1337. PubMed ID: 16333870
    [No Abstract]   [Full Text] [Related]  

  • 20. State of the biotech sector - 2006.
    Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):706. PubMed ID: 17621283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.